BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6327796)

  • 1. Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor.
    Del Prato S; Rovira A; Tessari P; Avogaro A; Nosadini R; Valverde I; Trevisan R; Tiengo A
    J Endocrinol Invest; 1984 Apr; 7(2):111-5. PubMed ID: 6327796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma proglucagon-like component with a glucagon-secreting tumor. Effect of streptozotocin.
    Danforth DN; Triche T; Doppman JL; Beazley RM; Perrino PV; Recant L
    N Engl J Med; 1976 Jul; 295(5):242-5. PubMed ID: 180408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptozotocin effective for treating multiple-hormone-producing malignant islet cell tumor.
    Murata E; Tashiro S; Hiraoka T
    Jpn J Surg; 1985 Jan; 15(1):63-7. PubMed ID: 2985854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin and glucagon in rats with islet cell tumors induced by small doses of streptozotocin.
    Yoshino G; Kazumi T; Morita S; Baba S
    Can J Physiol Pharmacol; 1981 Aug; 59(8):818-23. PubMed ID: 6271376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant metastatic insulinoma treated with streptozotocin.
    Gefel A; Flatau E; Ayalon D; Papo J; Loewenthal M
    Clin Endocrinol (Oxf); 1975 Sep; 4(5):461-8. PubMed ID: 170028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant glucagonoma syndrome: response to chemotherapy.
    Marynick SP; Fagadau WR; Duncan LA
    Ann Intern Med; 1980 Sep; 93(3):453-4. PubMed ID: 6254416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune reactions in a patient with malignant insulinoma treated by multiple low dose streptozotocin.
    Schulz B; Hehmke B; Zander E; Ziegler B
    Exp Clin Endocrinol; 1990 Feb; 95(1):77-82. PubMed ID: 2159401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of streptozotocin on an islet cell carcinoma with hypercalcemia.
    DeWys WD; Stoll R; Au WY; Salisnjak MM
    Am J Med; 1973 Nov; 55(5):671-6. PubMed ID: 4356099
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic characterization of plasma glucagon components in a patient with malignant glucagonoma.
    Tanaka K; Watabe T; Shimizu N; Horiuchi T; Nakamura K; Yoshida H
    Metabolism; 1984 Aug; 33(8):728-33. PubMed ID: 6087085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of malignant metastatic pancreatic insulinoma with streptozotocin. Review of 21 cases described in detail in the literature and report of complete remission of a new case.
    Herbai G; Lundin A
    Acta Med Scand; 1976; 200(6):447-52. PubMed ID: 189576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic polypeptide-secreting islet-cell tumors. A study of three cases.
    Tomita T; Friesen SR; Kimmel JR; Doull V; Pollock HG
    Am J Pathol; 1983 Nov; 113(2):134-42. PubMed ID: 6314815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma.
    Valverde I; Lemon HM; Kessinger A; Unger RH
    J Clin Endocrinol Metab; 1976 May; 42(5):804-8. PubMed ID: 178682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose intolerance in a patient with insulinoma. Report of a case.
    Christiansen J; Munkgaard S
    Acta Chir Scand; 1974; 140(7):578-80. PubMed ID: 4376322
    [No Abstract]   [Full Text] [Related]  

  • 14. Pancreatic alpha cell tumors: case report and review of the literature.
    Lokich J; Anderson N; Rossini A; Hadley W; Federman M; Legg M
    Cancer; 1980 May; 45(10):2675-83. PubMed ID: 6247056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin secreting islet cell carcinoma treated with streptozotocin (apropose of a case)].
    Chevrel JP; Amouroux J; Attali JR; Izou H
    Med Chir Dig; 1976; 5(1):25-31. PubMed ID: 189143
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful control of intractable hypoglycemia using rapamycin in an 86-year-old man with a pancreatic insulin-secreting islet cell tumor and metastases.
    Bourcier ME; Sherrod A; DiGuardo M; Vinik AI
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3157-62. PubMed ID: 19567519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
    Torre L; Vazquez JA; Blázquez E
    Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of propranolol on glucose-induced insulin response in rats with insulinomas.
    Yoshino G; Kazumi T; Morita S; Kobayashi N; Terashi K; Baba S
    Endocrinol Jpn; 1980 Dec; 27(6):775-8. PubMed ID: 6266820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma proinsulin in patients with functioning pancreatic islet cell tumors.
    Sherman BM; Pek S; Fajans SS; Floyd JC; Conn JW
    J Clin Endocrinol Metab; 1972 Aug; 35(2):271-80. PubMed ID: 4342038
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
    Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
    Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.